Literature DB >> 1698742

Optic nerve involvement in viral spread in herpes simplex virus type 1 retinitis.

M E Bosem1, R Harris, S S Atherton.   

Abstract

Colchicine was used to block fast axonal transport of the optic nerve of the uninjected eye after uniocular anterior chamber inoculation of herpes simplex virus type 1 (HSV-1). The results of these experiments suggest that second-wave virus is transported to the retina of the uninjected contralateral eye through the optic nerve of the uninjected eye, since intravitreal treatment with colchicine reduced both the viral titer and prevalence of animals with histopathologic evidence of retinitis. The chemical block to viral entry provided by colchicine was both dose- and time-dependent, with administration of colchicine that was timed to interfere with the second viral wave being the most effective. Colchicine did not appear to be directly inhibitory to viral replication or toxic to the virus, and colchicine did not cause clinical or microscopic evidence of retinal inflammation. Intravitreal injection of colchicine did not alter the timing or recovery of the first wave of virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698742

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Interferon-gamma, macrophages, and virus spread after HSV-1 injection.

Authors:  Heather M Cathcart; Mei Zheng; Jason J Covar; Yi Liu; Robert Podolsky; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-07       Impact factor: 4.799

2.  The herpesvirus VP1/2 protein is an effector of dynein-mediated capsid transport and neuroinvasion.

Authors:  Sofia V Zaichick; Kevin P Bohannon; Ami Hughes; Patricia J Sollars; Gary E Pickard; Gregory A Smith
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

3.  T-cell subsets and T-cell receptor V beta utilization by Igh-1-congenic mice in herpetic retinal necrosis.

Authors:  A Berra; A Heiligenhaus; C S Foster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  Rapid spread of a neurovirulent strain of HSV-1 through the CNS of BALB/c mice following anterior chamber inoculation.

Authors:  Nancy M Archin; Sally S Atherton
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

5.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Virus spread and immune response following anterior chamber inoculation of HSV-1 lacking the Beclin-binding domain (BBD).

Authors:  Ming Zhang; Jason Covar; Nancy Y Zhang; Wen Chen; Brendan Marshall; Juan Mo; Sally S Atherton
Journal:  J Neuroimmunol       Date:  2013-04-21       Impact factor: 3.478

7.  Infiltrating cells and IFNgamma production in the injected eye after uniocular anterior chamber inoculation of HSV-1.

Authors:  Heather M Cathcart; Mark A Fields; Mei Zheng; Brendan Marshall; Sally S Atherton
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05       Impact factor: 4.799

Review 8.  Anterior segment mechanisms of protection during herpes simplex virus 1 infection.

Authors:  Sally S Atherton; Heather M Cathcart
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

9.  Colchicine as a possible therapeutic option in COVID-19 infection.

Authors:  Rafael Parra-Medina; Juan Camilo Sarmiento-Monroy; Adriana Rojas-Villarraga; Edgar Garavito; Giovanni Montealegre-Gómez; Arley Gómez-López
Journal:  Clin Rheumatol       Date:  2020-06-18       Impact factor: 2.980

10.  Japanese encephalitis virus-induced neuropathology in mouse model infected through the conjunctival route.

Authors:  Menaka Sethi; Tareni Das; Neelam Tomar; Jeny K John; Zunjar B Dubal; Kaushal K Rajak; Rajendra Singh; G Saikumar
Journal:  Indian J Med Res       Date:  2019-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.